Literature DB >> 26033543

Treatment outcomes of sinonasal malignant melanoma: a Korean multicenter study.

Tae-Bin Won1, Kyu Young Choi2, Chae-Seo Rhee3, Hong-Ryul Jin4, Jong Sook Yi5, Hun-Jong Dhong6, Sung Won Kim7, Ji Ho Choi8, Jin Kook Kim9, Young-Jun Chung10, Yong-Min Kim11, Sang-Wook Kim12, Jung Soo Kim13, Sam Hyun Kwon14, Sang-Chul Lim15, Hwan-Jung Roh16.   

Abstract

BACKGROUND: The aim of this work was to evaluate factors that influence local recurrence and survival after surgical resection of sinonasal malignant melanoma, using a large population-based multicenter study in Korea.
METHODS: Retrospective analysis was performed for 155 newly diagnosed sinonasal malignant melanoma patients gathered from 15 university hospitals throughout Korea. Demographic data, tumor characteristics, surgical approach, adjuvant treatment, recurrence, and outcomes were analyzed.
RESULTS: Three-year and 5-year overall survival rates were 48.8% and 40.1%, respectively. Local recurrence rate was 46.6%, with a mean recurrence time of 15.5 months. On multivariate analysis, patients who underwent surgery that included an endoscopic approach showed decreased local recurrence rate (p = 0.042) and increased survival rate (hazard ratio [HR], 1.702; 95% confidence interval [CI], 1.007 to 2.875; p = 0.047) compared to those who underwent an external approach. Patients with postoperative radiotherapy showed a decreased local recurrence rate (p = 0.001), but without impact on survival rate. Male gender, tumor beyond the nasal cavity, and presence of distant metastasis were associated with poor survival.
CONCLUSION: An endoscopic-including surgical approach was associated with improved local control and survival in sinonasal malignant melanoma patients. Postoperative radiotherapy helped increase the local control rate.
© 2015 ARS-AAOA, LLC.

Entities:  

Keywords:  melanoma; nasal cavity; paranasal sinuses; recurrence; survival

Mesh:

Year:  2015        PMID: 26033543     DOI: 10.1002/alr.21558

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

1.  Primary Sinonasal Malignant Melanoma: Effect of Clinical and Histopathologic Prognostic Factors on Survival.

Authors:  Sercan Göde; Göksel Turhal; Ceyda Tarhan; Banu Yaman; Gülşen Kandiloğlu; Kerem Öztürk; İsa Kaya; Raşit Midilli; Bülent Karcı
Journal:  Balkan Med J       Date:  2017-04-06       Impact factor: 2.021

2.  Minimally invasive endoscopic resection for the treatment of sinonasal malignancy: the outcomes and risk factors for recurrence.

Authors:  Ning He; Xiaohong Chen; Luo Zhang; Xuejun Chen; Zhigang Huang; Qi Zhong; Hongzhi Ma; Ling Feng; Lizhen Hou; Jugao Fang
Journal:  Ther Clin Risk Manag       Date:  2017-05-03       Impact factor: 2.423

3.  The Prognostic Role of the Surgical Approach and Adjuvant Therapy in Operable Mucosal Melanoma of the Head and Neck.

Authors:  GilJoon Lee; Chung-Hwan Baek; Na Yeon Choi; Man Ki Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-01       Impact factor: 3.372

4.  Sinonasal Malignant Melanoma Variant: A Case Report.

Authors:  Alshema Alqurashi; Omar Ayad N Alsulami; Mohammad O Albakrei; Rehab Fadag
Journal:  Cureus       Date:  2022-08-09

5.  Surgical Treatment of Sinonasal Mucosal Melanoma in Patients Treated with Systemic Immunotherapy.

Authors:  Tiffany N Chao; Edward C Kuan; Charles C L Tong; Michael A Kohanski; M Sean Grady; James N Palmer; Nithin D Adappa; Bert W O'Malley
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-07

Review 6.  Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity : A single center experience and review of literature.

Authors:  Alexandros Andrianakis; Peter Kiss; Markus Pomberger; Axel Wolf; Dietmar Thurnher; Peter Valentin Tomazic
Journal:  Wien Klin Wochenschr       Date:  2021-04-12       Impact factor: 1.704

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.